(Q35293165)

7 August 2017

1 reference

title

Visual dysfunction, neurodegenerative diseases, and aging (English)

1 reference

7 August 2017

1 reference

Gregory R Jackson

1

1 reference

PubMed ID

13677819

7 August 2017

Cynthia Owsley

series ordinal

2

1 reference

PubMed ID

13677819

7 August 2017

language of work or name

1 reference

1 August 2003

1 reference

7 August 2017

1 reference

7 August 2017

21

1 reference

7 August 2017

3

1 reference

7 August 2017

709-728

1 reference

Review of the visual system in Parkinson's disease.

7 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Vision in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Ophthalmologic manifestations of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

The Framingham Eye Study. I. Outline and major prevalence findings

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Prevalence of age-related lens opacities in a population. The Beaver Dam Eye Study

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Comparison of acuity, contrast sensitivity, and disability glare before and after cataract surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Contrast sensitivity and glare sensitivity changes with three types of cataract morphology: are these techniques necessary in a clinical evaluation of cataract?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Improved visual function and attenuation of declines in health-related quality of life after cataract extraction.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

National study of cataract surgery outcomes. Variation in 4-month postoperative outcomes as reflected in multiple outcome measures.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Prevalence of age-related maculopathy. The Beaver Dam Eye Study

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Photoreceptor degeneration and dysfunction in aging and age-related maculopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Symptomatic abnormalities of dark adaptation in patients with age-related Bruch's membrane change

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Delays in rod-mediated dark adaptation in early age-related maculopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Early color vision changes in age-related maculopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Contrast sensitivity in macular disease. A preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Influence of age-related maculopathy on visual functioning and health-related quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

The psychosocial impact of macular degeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Number of people with glaucoma worldwide

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Psychophysical measurement of glaucomatous damage

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Influence of glaucomatous visual field loss on health-related quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

The role of medical therapy in the rank order of glaucoma treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Potential neuroprotective therapy for glaucomatous optic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Association of hue discrimination loss and diabetic retinopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

What effect does laser photocoagulation have on driving visual fields in diabetics?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Visual function after pan-retinal photocoagulation: a survey

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Development of the 25-item National Eye Institute Visual Function Questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Senescent vision: is it all the fault of the lens?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Contrast sensitivity throughout adulthood

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Spatial contrast sensitivity. Importance of controlling the patient's visibility criterion

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Aging and neural spatial contrast sensitivity: photopic vision

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Aging, senile miosis and spatial contrast sensitivity at low luminance

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Aging and luminance-adaptation effects on spatial contrast sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Senescent changes in scotopic contrast sensitivity.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

A new contrast sensitivity vision test chart

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

1 reference

7 January 2021

Seeing into old age: vision function beyond acuity

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Further studies on acquired deficiency of color discrimination

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Age and illuminance effects in the Farnsworth-Munsell 100-hue test

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Variation of chromatic sensitivity across the life span

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Studies on the Effects of Age on the Central and Peripheral Isopters of the Visual Field in Normal Subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

The normal visual field on the Humphrey field analyzer

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Influence of age on the visual fields of normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Age and sex differences in critical flicker frequency

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

The relationship between critical flicker frequency and chronologic age for varying levels of stimulus brightness.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

The influence of age on the spatial and temporal contrast sensitivity function.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Foveal flicker sensitivity in healthy aging eyes. I. Compensating for pupil variation

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Improving visual perception in older observers.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Human aging and spatial vision

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Topography of the age-related decline in motion sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Scotopic sensitivity during adulthood.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Aging and dark adaptation.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Visual Changes in Daily Life Throughout Adulthood

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

AN AGE-DECREMENT IN THE ABILITY TO IGNORE IRRELEVANT INFORMATION.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Age and visual search: expanding the useful field of view

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Visual processing impairment and risk of motor vehicle crash among older adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Vision impairment, eye disease, and injurious motor vehicle crashes in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Distribution and synaptic organization of dopaminergic axons in the lateral geniculate nucleus of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Dopamine in the visual cortex of the cat.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Evidence for a dopaminergic innervation of cat primary visual cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Measurements of visual evoked potentials in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Visual and auditory evoked responses in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Temporal frequency-dependent VEP changes in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Dopaminergic deficiency and delayed visual evoked potentials in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Visual evoked cortical potentials and pattern electroretinograms in Parkinson's disease and control subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Alteration of visual evoked potentials and electroretinograms in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Ganzfeld electroretinographic findings in parkinsonism: untreated patients and the effect of levodopa intravenous infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Visual system abnormalities in patients with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Low contrast stimuli enhance PERG sensitivity to the visual dysfunction in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

An electrophysiological study of D2 dopaminergic actions in normal human retina: a tool in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Visual contrast response functions in Parkinson's disease: evidence from electroretinograms, visually evoked potentials and psychophysics

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Low-contrast letter charts in early diabetic retinopathy, ocular hypertension, glaucoma, and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Visual dysfunction in Parkinson's disease. Loss in spatiotemporal contrast sensitivity.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Orientation-selective visual loss in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Effect of stimulus orientation on contrast sensitivity in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Abnormalities in color vision and contrast sensitivity in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

L-Dopa improves colour vision in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Distorted color discrimination in 'de novo' parkinsonian patients

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Effects of apomorphine on visual functions in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Color vision in Parkinson's disease: missing influence of amantadine sulphate

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Colour discrimination thresholds in Parkinson's disease: results obtained with a rapid computer-controlled colour vision test

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Acquired colour deficiency in patients with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Distribution of cerebral degeneration in Alzheimer's disease. A clinico-pathological study

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Optic-nerve degeneration in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Retinal ganglion cells in Alzheimer's disease and aging.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Presenile dementia—the use of the flash and pattern vep in diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Visual evoked response in senile and presenile dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Serial visual evoked potential recordings in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Pathology of the optic nerve and visual association areas. Information given by the flash and pattern visual evoked potential, and the temporal and spatial contrast sensitivity function

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

The flash and pattern VEP as a diagnostic indicator of dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Changes in the human visual evoked potential caused by the anticholinergic agent hyoscine hydrobromide: comparison with results in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Primary presenile dementia: the use of the visual evoked potential as a diagnostic indicator.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Visual evoked potentials (VEPs) in senile dementia (Alzheimer type) and in non-organic behavioural disorders in the elderly; comparison with EEG parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Abnormal pattern electroretinogram in Alzheimer's disease: evidence for retinal ganglion cell degeneration?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Abnormal pattern electroretinograms in patients with senile dementia of the Alzheimer type.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Visual processing deficits as assessed by spatial frequency contrast sensitivity and backward masking in normal ageing and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Visual dysfunction in Alzheimer's disease: relation to normal aging

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Visual Function in Alzheimer's Disease and Normal Aginga

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Incomplete achromatopsia in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Visual dysfunction predicts cognitive deficits in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Perception of movement and shape in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Attention and driving performance in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Spatial Contrast Sensitivity in Alzheimer??s Disease: A Comparison of Two Methods

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Motion perception and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Spatial vision in Alzheimer's disease. General findings and a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Alzheimer's disease with prominent visual symptoms. Clinical and metabolic evaluation.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Assessment of visual impairment in patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Prevalence of visual deficits in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Complex visual disturbances in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

The visual variant of Alzheimer's disease: a clinicopathologic case study.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Impact of adult age and Alzheimer's disease on levels of neural noise for letter matching

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Object recognition deficit in Alzheimer's disease: Possible disconnection of the occipito-temporal component of the visual system

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Selective attention skills in Alzheimer's disease: performance on graded cancellation tests varying in density and complexity

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

The decline of working memory in Alzheimer's disease. A longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Driving performance in persons with mild senile dementia of the Alzheimer type.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Selective disconnection of specific visual association pathways in cases of Alzheimer's disease presenting with Balint's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Visuospatial attention in dementia of the Alzheimer type

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Spatial recognition and spatial order memory in patients with dementia of the Alzheimer's type

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Balint's syndrome in Alzheimer's disease: specific disruption of the occipito-parietal visual pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Spatial and visual learning deficits in Alzheimer's and Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Posterior cortical atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Visual disturbances with focal progressive dementing disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Optic nerve damage in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Retinocalcarine function in Alzheimer's disease. A clinical and electrophysiological study.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

A potential noninvasive neurobiological test for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

The 'eye test' in recognition of late-onset Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Can tropicamide eye drop response differentiate patients with progressive supranuclear palsy and Alzheimer's disease from healthy control subjects?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Pupillary response to tropicamide in patients with Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Motion perception and aging

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

Age and the selectivity of visual information processing

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2802%2900107-X

7 January 2021

10.1016/S0733-8619(02)00107-X

Identifiers

DOI

1 reference

7 August 2017

1 reference

PubMed ID

13677819